GLP-1s may be thinning more than just men’s waistlines, a shocking new review has found.Drugs like Ozempic and Zepbound have exploded into the mainstream market—but so have anecdotal reports of hair thinning among patients, says a systematic review published in Science Progress.The review found that male patients were seven percent more likely to experience hair loss if they had higher amounts of the gene that GLP-1 medications create.
